Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Evgen Pharma ( (GB:TCF) ) has issued an announcement.
TheraCryf PLC, a company listed on the stock exchange, has announced a change in its major holdings. Andrew Leach has acquired a significant portion of voting rights, totaling 3.7565%, as of March 11, 2025. This acquisition could influence the company’s decision-making process and potentially impact its strategic direction.
More about Evgen Pharma
YTD Price Performance: -57.14%
Average Trading Volume: 2,247,055
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £4.79M
See more insights into TCF stock on TipRanks’ Stock Analysis page.